Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Patients with specific types of lipids may be at higher risk of developing blinding eye disease

June 13, 2023
Epidemiology Glaucoma Optic Nerve Disorders
Clinical Research
Grantee

Louis Pasquale, Mount Sinai Health System, and collaborators Oana Zeleznik and Jae Kang, Harvard University, discovered that lipid metabolism is dysregulated in and associated with primary open-angle glaucoma, the most common type of glaucoma.

Based on data from thousands of study participants, the researchers found that higher levels of two lipids—diglycerides (DGs) and triglycerides (TGs)—were associated with an increased risk of glaucoma. The findings of high TGs and high DGs and glaucoma raise questions about whether statin use could correct dyslipidemia and lower the risk of glaucoma.

Mount Sinai news story